The NuLids Starter Kit – Nulids at-Home Dry Eye Treatment and Relief – Convenient & Easy to Use Handheld Device for Relief from Dry Eye, Blepharitis, MGD Symtpoms - Includes 30 Day Supply Of Soft Tips

Product Information

National Center for Advancing Translational Sciences. Development of P-321 for chronic dry eye. October 26, 2018. https://ncats.nih.gov/bridgs/projects/complete/p-321-chronic-dry-eye. Accessed February 9, 2019. Sight Sciences presents additional results of OLYMPIA study of signs and symptoms of dry eye disease using TearCare. Eyewire News. eyewire.news/articles/sight-sciences-presents-additional-results-of-olympia-study-of-signs-and-symptoms-of-dry-eye-disease-using-tearcare/. September 9, 2020. Accessed February 16, 2021.

At-home gland expression (0). For maintenance, patients may perform manual gland expression at home. While looking down, the patient should apply mild force on the nasal upper lid in a downward motion toward the lash line, progressing laterally across the lid to express all glands. The bottom lid should be expressed similarly with the patient looking up. Appropriate supraduction or infraduction during massage prevents direct mechanical force to the cornea, which could lead to corneal deformation. Alternatively, patients may squeeze sections of the upper and lower lids between their index finger and thumb. 36 Take-home Message Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 and older. Am J Ophthalmol. 2017 Oct;182:90-98. Fig. 2. Moderate-to-severe ocular staining is best managed with anti-inflammatories. Artificial tears with lubricants with anti-inflammatory-containing properties such as trehalose could be beneficial in these cases.Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2018;102(1):59-68. ProKera™ is available as a device that can be placed on a patient’s eye in the office and has a ring that holds the amniotic membrane transplant (AMT) in place. The original ProKera™ is indicated for moderate to severe indications, including neurotrophic PED, severe infectious keratitis, post-PRK haze, and Salzmann nodular degeneration; however, Bio-tissue recently started offering the ProKera™ SLIM and ProKera™ PLUS. The ProKera™ SLIM is indicated for mild to moderate conditions, while the ProKera™ PLUS is recommended for severe indications that require longer treatment. Meerovitch K, Torkildsen G, Lonsdale J, et al. Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye. Clin Ophthalmol. 2013;7:1275-85. Fariselli C, Giannaccare G, Fresina M, Versura P. Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients. Clin Ophthalmol. 2018;12:1293-1300.

But when your eyes feel dry and gritty every day — as a result of aging, underlying health conditions, certain prescription drugs or long hours staring at a computer screen— your doctor may suggest a stronger treatment. A traditional treatment involves placing tiny devices called punctal plugs into your tear ducts to keep your natural tears in your eye. Xiao J, Adil MY, Chen X, et al. Functional and morphological evaluation of the meibomian glands in the assessment of meibomian gland dysfunction subtype and severity. Am J Ophthalmol. 2020;209:160-7.Perhaps the most well known scleral lens used to treat ocular surface disease is the BostonSight® PROSE (Prosthetic Replacement of the Ocular Surface Ecosystem) lens (Boston Foundation for Sight, Needham, MA). The PROSE lens is custom designed using patient eye measurements so that the lens is not touching the apical or peripheral cornea but still maintaining minimal movement and optimizing fluid ventilation. An early retrospective review of 49 consecutive patients (76 eyes) with ocular surface disease treated with this lens found a 92% improvement in quality of life as a result of reduction in photophobia and pain. 53% of patients in this study achieved 2 or more Snellen lines of improvement in visual acuity. 67 Agranat et al. reported long-term follow-up data and found that 64% of patients using PROSE for ocular surface disease reported continued wear at five years. In patients with OSD and continued wear at give years, National Eye Institute Visual Function Questionnaire (NEI VFQ-25) scores increased initially and after five years of wear (mean increase +27.17 and +18.80, respectively). 68 A number of other retrospective studies have further demonstrated the ability of PROSE to significantly improve dry eye signs and symptoms in OSD, including various cases that result from Stevens Johnson Sydrome, chronic GVHD, and even neurotrophic keratopathy following skull base tumor resection. 69– 75 In a prospective, interventional case series of 38 patients with ocular surface disease, Stason et al. reported that PROSE significantly improved visual acuity and visual functioning, according to the NEI VFQ-25. 76 NuLids is comfortable and easy to use. Nulids offers a comfortable treatment that is convenient to use everyday. Llamas-Moreno JF, Baiza-Durán LM, SaucedoRodríguez LR, Alaníz-De la O JF. Efficacy and safety of chondroitin sulfate/xanthan gum versus polyethylene glycol/propylene glycol/hydroxypropyl guar in patients with dry eye. Clin Ophthalmol 2013;7:995-9 Patients presenting with ocular burning, stinging and sometimes painful symptoms of dry eye disease (DED) are becoming more common in today’s optometric practice. More than 16 million Americans are coping with this disease, which can have a significant impact on quality of life. 1-3In addition, DED is a growing problem for both mature patients and young adults. 1,3 O ur understanding of the multifactorial nature of meibomian gland dysfunction (MGD) has evolved significantly since the early 1980s when the term “MGD” was first coined. 1 There is now a wealth of in-office interventions practitioners can implement in addition to at-home maintenance therapies. 2,3 Despite advancements in MGD treatment, however, these procedures are not fully covered by insurance and can pose a significant cost to the patient. By developing our comprehensive knowledge of MGD therapies, we as practitioners can more effectively identify which procedures will benefit the greatest number of patients, balance improvement in quality of life with cost and build patient loyalty within our practices. Exploring MGD

RF: What makes NuLids so exciting is that it helps solve problems for both the doctor and the patient. Patients are constantly battling their DED [dry eye disease] symptoms and often have them return well before their next scheduled appointment. A major advantage of the eyeXpress is that it’s not user dependent,” he continues. “You can put it on the eyes and leave. Some of the other devices need a technician and/or have to be held up to the face by the patient. Kim CE, Kleinman, HK, Sosne G, et al. RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model. Scientific Reports. 2018 July;8(10500).Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions. Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II report executive summary. Ocul Sur. 2017;15(4):802-12. Asiedu K, Dzasimatu SK, Kyei S. Impact of dry eye on psychosomatic symptoms and quality of life in a healthy youthful clinical sample. Eye Cont Lens. 2018;44(Suppl 2):S404-09.